Maciej Banach: Ischemic Stroke is a Significant Global Health Challenge
Maciej Banach, Vice-Rector for the Collegium Medicum at John Paul II Catholic University of Lublin, shared on LinkedIn:
”Ischemic Stroke is a significant global health challenge, accounting for approximately 66% of all strokes worldwide
Recent data indicates that stroke was the third leading cause of death (10.7 % of all deaths), following ischemic heart disease IHD and COVID19.
In 2021, nearly 94 million people were living with the consequences of a stroke, and about 12 million new cases were reported
The issue is we cannot still effectively prevent the first and recurrent stroke (there are still 74 thousands strokes in Poland annually), thus the International Lipid Expert Panel (ILEP) in collaboration with the experts of the European Society of Cardiology Council on Stroke, has prepared a practical guidance on how to prevent stroke with optimal combination lipid lowering therapy LLT both in primary and secondary prevention.
Thanks to everyone for an amazing collaboration at this paper.”
Read the full article here.
Article: Lipid management for primary and secondary stroke prevention consensus paper of the International Lipid Expert Panel (ILEP)
Authors: Maciej Banach, Peter P. Toth, Hyo-Jeong Ahn, Agata Bielecka-Dabrowa, Arrigo F.G. Cicero, Adrian Covic, Mayank Dalakoti, Carlos Escobar, Federica Fogacci, Dan Gaita, Laura Gaita, Jacek Jóźwiak, Gustavs Latkovskis, Joanna Lewek, George Ntaios, Boguslaw Okopień, Ivan Pećin, Daniel Pella, Peter E. Penson, Marco Proietti, Jakub Sadowski, Bogdan Solnica, Bozena Sosnowska, Margus Viigimaa, Gregory Y.H. Lip

Stay updated on all scientific advances with Hemostasis Today.
-
Mar 7, 2026, 16:24Kalpana Gupta Shekhawat: The Overlooked Regulator of Mast Cells – Understanding the Vagus Nerve
-
Mar 7, 2026, 16:20Purusotham Chippala: How DALYs Reveal the True Burden of Stroke
-
Mar 7, 2026, 16:13Ilenia Calcaterra: Patient-Level Real-World Outcomes of Emicizumab in Acquired Hemophilia A
-
Mar 7, 2026, 16:05Iyas Daghlas: DOACs Use, Genetic Reduction of Coagulation Factors and Risk of Cerebral Venous Thrombosis
-
Mar 7, 2026, 15:58Aurelio Maggio: The Mission and The Projects We Are Advancing for Rare Hematologic Diseases
-
Mar 7, 2026, 15:52Faizan Khan: The Importance of Cancer Site in Bleeding Risk Stratification for Cancer-Associated VTE
-
Mar 7, 2026, 15:50Heghine Khachatryan: How DOACs Can Cause False-Positive FVIII Inhibitor Results
-
Mar 7, 2026, 15:43Gevorg Tamamyan Joins The London Global Cancer Week Steering Group
-
Mar 7, 2026, 15:36Kenneth Monaghan: Empowering Stroke Survivors’ Self-Efficacy Through Neuroplasticity and Daily Activity